Navigation Links
Cardiologists Need Guidelines Diagnosing, Treating Depression

Cardiologists know that treating depression likely will benefit patients complaining of cardiovascular problems, but lack the guidance to properly diagnose or recommend treatment for depression//, according to a report out today from a National Heart, Lung and Blood Institute (NHLBI) Working Group.

According to the report, up to 20 percent of patients with heart disease meet the American Psychiatric Association’s criteria for major depression, and identifying better treatments for depression in this population could lead to improved medical, financial and psychosocial outcomes.

“One major aspect of the problem is that cardiologists don’t have a standard assessment to diagnose depression,” said Karina Davidson, Ph.D., chair of the NHLBI Working Group and co-director of the Behavioral Cardiovascular Health and Hypertension Center at Columbia University Medical Center. “It’s important that research in this area move forward so cardiologists can confidently address the issue of depression, knowing that their patients are getting the most appropriate and effective therapy.”

Dr. Davidson pointed out that antidepressant prescription use in heart attack patients is steadily rising, but in the absence of a large clinical trial that would clearly indicate the best way to treat depression in these cases.

There are a number of ways treating depression may impact cardiovascular health. Antidepressants may normalize platelet reactivity, which is implicated in leading to heart attacks. Also, depressed patients tend not to follow medical recommendations, so treating depression may influence them to take prescribed medications or follow other guidance from doctors.

Although depressed patients might be more likely to have cardiovascular risk factors such as increased weight and a sedentary lifestyle, many studies reviewed by the NHLBI Working Group controlled for those factors and still found a relationship between depressi
'"/>




Page: 1 2

Related medicine news :

1. Cardiologists Do Not Recommend Life Saving Diet To Patients
2. Cardiologists Ignoring Treatment Of Depression
3. Indian President Urges Cardiologists to Focus on Preventive Care
4. New CPR Guidelines issued by Heart Association
5. New Guidelines Found To Benefit Cardiovascular Treatment
6. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
7. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
8. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
9. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
10. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
11. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
Post Your Comments:
(Date:10/10/2008)... PHILADELPHIA, Oct. 10 /PRNewswire/ -- The Mobil...), a leading provider of on-site seated massage,se...l events, and special,affairs, announced today tha...ern Pennsylvania and the greater Philadelphia metr... increasing interest in our on-site,seated, massa...
(Date:10/10/2008)... BALTIMORE, Oct. 10 /PRNewswire/ -- A nationally...reatment strategies for patients with breast,cance...east Cancer,Strategies: From Biomarkers to Treatme...ess Month., It is challenging for practicing onco... to stay up to date on the latest patient care,adv...
(Date:10/9/2008)... ROYAL PALM BEACH, Fla., Oct. 9 /PRNewswire/ -- ...ly cutting-edge reality. Internationally,acclaimed...rst U.S. doctor,licensed to provide TA-65 to the p...Palm Beach, Florida., This is a revolutionary tec...es are part of your DNA. They are located at the e...
(Date:10/9/2008)... Offering Healthy Rewards and Educational Opportun... Front Line, PHILADELPHIA, Oct. 9 /PRNewswire/ ...k, Independence Blue Cross (IBC) honors its more t...y rewarding them with fun,healthy activities this...ncement training., Fielding more than 4 million i...
Breaking Medicine News(10 mins):Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 3Health News:Independence Blue Cross Celebrates Customer Service Week 2
...-waste has resulted in the release of toxic chemic...eas of recycling yards yielding reason for concern...ing is that toxic chemicals are released during ea...cess into the workplace and in many cases into the...
...veloping inflammatory disorders like rheumatoid ar...oured fruits and vegetables like oranges, carrots ...ryptoxanthin, both of which are found in brightly-...t as antioxidants, and protect the body against th...
...im that a new protein identified can help in the t...betes. The protein has already shown promising res...es // and is known to keep blood sugar under contr...d that mice with an excess of the protein Sirt1 in...
...om Mayo Clinic had developed focused ultrasound to...tal for treating women suffering from uterinefibro...ce in treating this common condition that affects ..., because it is the first completely noninvasive t...
Other Medicine News:Health News:Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors 2
(Date:10/9/2008)... Campaign to Spread Awareness and Bring Hope to Mi...RNewswire-USNewswire/ -- 133 million children,acro...es such as natural,disaster, civil war, and diseas...ing World Orphan Week by calling attention to the ...ia News Release, go to:, http://www.prnewswire.c...
(Date:10/9/2008)...ober 9 /- Diamyd Medical re...urnal, the New England Journal,of Medicine, has pu... study,of the Diamyd(R) diabetes vaccine for type ...in/prnh/20080314/297194 ), The article is now av...m.org ) and will be in print on October 30. It pre...
(Date:10/8/2008)...b Program to be Discontinued and Headcount to be R...ts Portfolio Review; Zanolimumab Program to be Di...of Employees, COPEN...A/S (OMX: GEN),announced today that it is disconti...n addition, as a result of a portfolio review and,...
(Date:10/8/2008)... study shows clinical improvement in patients with... Current treatment options have limited benefit fo...incurable blood vessel disease, -- Imatinib mes...rtain cancers, known to inhibit protein assoc...potential of imatinib mesylate in PAH in 2009...
Breaking Medicine Technology:Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 1Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non Hodgkins Lymphoma 836 4Researchers take first steps towards spinal cord reconstruction following injury 1193 1Researchers take first steps towards spinal cord reconstruction following injury 1193 2Don Messer Will Speak in Upper Room Chapel to Observe World AIDS Day 6133 1Don Messer Will Speak in Upper Room Chapel to Observe World AIDS Day 6133 2Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 1Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 2Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 3Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 4Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 5Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 6Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 7Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 8Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 9Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 10Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 11Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 12Select Medical Corporation Announces Results for Third Quarter Ended September 30 2007 6128 13
... Data Presented at the , 2007 American Society of ...n(R) Activity in Older Patients with AML and in,Re...ation of the molecular interaction of Aloxi(R),wit... Survival Analysis of Glioblastoma Patients,Treate...Described-- , --Survival Analysis of Irofulven in ...
...was well-tolerated with signs of durable,disease c...lif., June 05, 2007 /PRNewswire-FirstCall/ -- IDM,...rom a Phase II,UVIDEM (IDD-3) melanoma vaccine cli...UVIDEM was well tolerated with evidence of,efficac...h,progressive metastatic melanoma. , The data were...
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5
Sealing Mat for 96-well PCR Plate, Natural
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times.
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk.
...l and Heat Sealing Film each provide 100% evaporat...fe and easy sample storage. In automated procedure... with standard pipette tips. The Heat Sealing Film...e in the plates. Heat Sealing Foil is removed by s...
Medicine Products: